This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 May 17;139(1):1-16.

doi: 10.1016/0022-1759(91)90345-g.

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer

Affiliations

PMID: 2040807
DOI: 10.1016/0022-1759(91)90345-g

Review

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer

J R Yannelli. J Immunol Methods. 1991.

. 1991 May 17;139(1):1-16.

doi: 10.1016/0022-1759(91)90345-g.

Author

Affiliation

¹ Biotherapeutics Inc., Franklin, TN 37064.

PMID: 2040807
DOI: 10.1016/0022-1759(91)90345-g

No abstract available

PubMed Disclaimer

Similar articles

Tumor-derived activated cells: culture conditions and characterization.
Maleckar JR, Friddell CS, Lewko WM, Yannelli JR, West WH, Oldham RK. Maleckar JR, et al. Immunol Ser. 1989;48:159-73. Immunol Ser. 1989. PMID: 2488319 Clinical Trial. No abstract available.
Therapy with interleukin-2 and tumor-derived activated lymphocytes.
Oldham RK. Oldham RK. Immunol Ser. 1994;61:251-71. Immunol Ser. 1994. PMID: 8011748 Review. No abstract available.
Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.
Wolf JA Jr, Grimm EA. Wolf JA Jr, et al. Curr Opin Oncol. 1989 Dec;1(2):249-57. Curr Opin Oncol. 1989. PMID: 2489968 Review. No abstract available.
Lymphokine-activated killer lymphocytes: extramural clinical trials.
Sniecinski IJ. Sniecinski IJ. Immunol Ser. 1989;48:59-77. Immunol Ser. 1989. PMID: 2488326 Clinical Trial. No abstract available.
[Immunotherapy of malignant melanoma].
Flageul B, Miclea JM, Bensussan A, Degos L. Flageul B, et al. Pathol Biol (Paris). 1990 Oct;38(8):881-2. Pathol Biol (Paris). 1990. PMID: 2274397 French. No abstract available.

See all similar articles

Cited by

Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy.
Garcia-Aponte OF, Herwig C, Kozma B. Garcia-Aponte OF, et al. J Biol Eng. 2021 Apr 13;15(1):13. doi: 10.1186/s13036-021-00264-7. J Biol Eng. 2021. PMID: 33849630 Free PMC article. Review.
Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment.
Mulder WM, Koenen H, van de Muysenberg AJ, Bloemena E, Wagstaff J, Scheper RJ. Mulder WM, et al. Cancer Immunol Immunother. 1994 Apr;38(4):253-8. doi: 10.1007/BF01533516. Cancer Immunol Immunother. 1994. PMID: 8168120 Free PMC article.
Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.
Yoong KF, Adams DH. Yoong KF, et al. Br J Cancer. 1998 Apr;77(7):1072-81. doi: 10.1038/bjc.1998.179. Br J Cancer. 1998. PMID: 9569042 Free PMC article.
Identification of the promoter of the mouse obese gene.
de la Brousse FC, Shan B, Chen JL. de la Brousse FC, et al. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4096-101. doi: 10.1073/pnas.93.9.4096. Proc Natl Acad Sci U S A. 1996. PMID: 8633022 Free PMC article.
Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface.
Ivanova OK, Sharapova TN, Romanova EA, Yashin DV, Sashchenko LP. Ivanova OK, et al. Dokl Biochem Biophys. 2023 Feb;508(1):12-16. doi: 10.1134/S160767292270003X. Epub 2023 Jan 18. Dokl Biochem Biophys. 2023. PMID: 36653582 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science